Login / Signup

Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Shalini S RaoLarissa LagoIrene VolitakisJay J ShuklaGawain McCollDavid I FinkelsteinPaul A Adlard
Published in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2023)
Keyphrases
  • cerebrospinal fluid
  • type diabetes
  • combination therapy
  • insulin resistance
  • wild type